Your browser does not support JavaScript or it may be disabled!

NewsApp (Free)

Read news as it happens
Download NewsApp
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News Home   |   Images Home
 rediff News App

About 1364 results for "pharma"

Wintac: Updates on open offer

GAVIS Pharma LLC, U.S.A together with Kali Capital LP, U.S.A. has acquired 15,12,098 equity shares of Wintac via open offer. Money Control, 34 minutes ago

3,729 images for pharma

Pharma Times, 3 hours ago
Pharma Times, 3 hours ago
Irish Independent, 1 day ago
Irish Times, 1 day ago
92.9 WLMI, 1 day ago
MedIndia, 1 day ago
VietNamNet Bridge, 1 day ago
Irish Times, 3 days ago
4 Traders, 2 days ago
AdNews, 5 hours ago
Money Control

Time to nibble; bet on IT, auto, FMCG, pharma: Edelweiss

He recommends putting money into FMCG, IT, pharma and auto stocks. "Another 50bps rate cut is likely by year- end, with fall in interest rates consumption theme should be back," he told CNBC-TV18 in an interview.
 Money Control42 minutes ago
Money Control

BSE Sensex down 400 pts; Sun Pharma, Wipro outperform

Sun Pharma, TCS and Wipro are gainers in the Sensex as most stocks are reeling under selling pressure. Jindal Steel (down 6.34 percent), Hindalco, Tata Steel, ICICI Bank and Sterlie Industries are key losers in the Sensex.
 Money Control2 hours ago BSE Sensex down 378 pts; Sun Pharma, TCS, Wipro outperform  Money Control5 hours ago BSE Sensex, Nifty weak; banks, oil gas, pharma outperform  Money Control1 week ago BSE Sensex flat; Hero, Wipro up 2%, Jindal Steel weak  Money Control1 week ago

Form 8-K MEI Pharma, Inc. For: Jun 18

StreetInsider.com - Form 8-K MEI Pharma, Inc. For:
 Street Insider1 day ago BioAlliance Pharma Begins Phase II Clinical Trial in the U.S. with Validive  Individual.com2 days ago MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Initiates Phase II Clinical Trial of Pracinostat and Vidaza in Frontline Myelodysplastic Syndrome  BioSpace1 day ago MEI Pharma (MEIP) announces the dosing of the first patients in a Phase II trial of the myelodysplastic syndrome treatment Pracinostat, the company's lead candidate. CMO Robert Mass calls the initiation of Phase II clinicals "an important milestone." (PR)  Seeking Alpha1 day ago
[x]  

Relatively Low PEG Ratio Detected in Shares of WuXi PharmaTech Cayman in the Life Sciences Tools & Services Industry (WX, ICLR, MTD, CRL, QGEN)

(Comtex SmarTrend(R)) Below are the three companies in the Life Sciences Tools & Services industry with the lowest price to earnings to growth (PEG) ratios. PEG is valuable in assessing the tradeoff between the price of a stock and expected growth.
 Individual.com43 minutes ago Jubilant Life board appoints an additional director  Myiris3 days ago
Money Today

6/20/2013: FRONT PAGE: 146m euro fine on pharma firms for blocking cheap drugs

BRUSSELS: Nine drugmakers, including Denmark's Lundbeck, were fined a total of 146 million euros by EU anti-trust regulators on Wednesday for blocking the supply of a cheaper antidepressant medicine to the
 Hindustan Times10 hours ago EC fines 9 pharma companies, including Ranbaxy  The Statesman13 hours ago Ranbaxy to appeal against EU fine  Money Today19 hours ago European Commission fines Ranbaxy and 8 other pharma firms  ZeeNews.com21 hours ago
[x]  
Irish Times

Elan Proceeds with Formal Sale Process of Company; Royalty Pharma Drops Bid

The move follows rejection of Elan shareholders of certain key deals and withdrawal of Royalty Pharma bid. Elan announced on June 14, 2013, that it is proceeding with a formal sale process of the company and will invite Royalty Pharma, who had ...
 BioPharm International8 hours ago Royalty Pharma Drops Judicial Review Request of Elan Bid  Bloomberg1 day ago Royalty Pharma lets Elan takeover bid expire  Miami Herald1 day ago Royalty Pharma drops hostile bid for Elan  Reuters1 day ago
[x]  

Like pharma, FMCG and banking stocks: Vallabh Bhanshali, Enam Securities

In an interview with ET Now, Vallabh Bhanshali, Chairman, Enam Securities, shares his view on the rupee and Mr Murthy's return as the chairman of Infosys. Excerpts: ET Now: Is the rupee telling us the true story? It is often believed in the past ...
 Economic Times3 hours ago

Buy Mahindra Ugine, IVRCL, Alembic Pharma: Rajesh Agarwal

Rajesh Agarwal of Eastern Financiers suggests buying Mahindra Ugine Steel Company, IVRCL, Lakshmi Vilas Bank and Alembic Pharmaceuticals.
 Money Control3 hours ago
Money Control

Buy Sun Pharma with target price of Rs 980: Ashwani Gujral

n a chat with ET Now, Ashwani Gujral, Fund Manager, Ashwanigujral.com , shares his views on Sun Pharma. What is your call on Sun Pharma? Buy Sun Pharma at a stop loss of Rs 948 and target Rs 980. Follow Economic Times Views/Recommendations Section, For The ...
 Economic Times5 hours ago Buy Aurobindo Pharma Ltd with a target price of Rs 187: Sandeep Wagle  Economic Times2 days ago Buy Sun Pharma with a target of Rs 1,015: Ashwani Gujral  Economic Times3 days ago ICICI Sec retains Buy on Sun Pharma; cuts target to Rs 1,126  Myiris6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts
WidgetGet Realtime news on your homepage & get your members hooked.Add Realtime Widget
 rediff News App

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pharma
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
    
Widget
Get Realtime News on your webpage & get your members hooked!
 
More     Less